Opticul Diagnostics is an in-vitro diagnostics device company targeting easy and low cost clinical laboratory and point of care (POC) microorganism identification without the use of reagents.

Our technology offers specific, sensitive and rapid (within minutes) identification.

Other non-medical applications such as homeland security, combat conditions, clean tech and monitoring instrument contamination are considered.

The 2015 BIO International Convention June 15-18 in Philadelphia, Pennsylvania

Interview with Opticul Diagnostics Inc. president, Dr. Gallya Gannot

Link:

February 23, 2015 Opticul received the Montgomery county Impact award.

read more:

Comparison of Rapid Identification of Staphylococcus aureus and Streptococcus pyogenes by the Optidet ® and the Bruker Biotyper® MALDI-TOF MS. 

Read more: 

 The Optidet 3.0 finished a veru sucessful Clinical study at the Meir Hospital Center in Kfar Saba, Israel.

The two Optidets that participated in the study, on the bench at the Microbiology Laboratory at Meir Hospital.

Companies Present New Concepts at TechBreakfast, Johns Hopkins Montgomery County campus:

Read more:

Dr. Zvi Marom, BATM CEO near the OPTIDET 3.0 in MEDICA 2015.

The instrument got a lot of attention from distributors from arround the world.